The Strom Law Firm is now accepting product liability cases concerning the diabetes drug Actos and its link to bladder cancer.
Bladder cancer is a grueling and excruciating diagnosis. Estimations reveal that nearly 25% of the people diagnosed with bladder cancer will ultimately die from the disease.
Recent studies have found that Actos can increase the risk of bladder cancer in patients taking the drug for more than a year by approximately 40%. Despite these risks, Actos still remains on the market in theUnited States. It has been pulled in both France and Germany as a result of those same concerns.
Actos is a prescription medication, used with diet and exercise, to improve blood sugar control for type 2 diabetics. Actos is not for patients with type 1 “juvenile” diabetes, or those who suffer from diabetic ketoacidosis.
Actos works on two of the common problems that lead to high blood sugar:
- It helps your body better use the insulin it makes
- It also prevents your liver from making more sugar when it doesn’t need to
By regulating these symptoms, blood sugar can get to where it needs to go, and won’t continue to build up.
However, there are numerous side effects associated with the use of Actos. You should seek medical attention if you suffer from one or more of those side effects:
- irregular breathing, troubled breathing, or shortness of breath
- chest tightness or pain
- extreme fatigue
- irregular heartbeat
- dilated neck veins
- swelling of face, fingers, feet, or lower legs
- problems with teeth
- decreased urine output
- weight gain
The FDA is still evaluating the data on Actos in order to determine if further regulatory action is needed.
Have you been injured by Actos?
If you or a loved one has suffered a severe injury because of an Actos side effect, you could seek compensation for your losses and suffering.
Takeda Pharmaceuticals North America Inc., the maker of Actos, released a statement saying it remains positive about the drug:
“We are confident in the therapeutic benefits of Actos and its importance as a treatment for type 2 diabetes. The company remains committed to Actos and Actos-containing medications, and to the millions of people living with the disease.”